Member access

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)

4
 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Oslo Bors
07/18/2014 07/21/2014 07/22/2014 07/23/2014 07/24/2014 Date
21.8 21.5 22 21.8 21.9 Last
5000 5000 7120 602 250 Volume
-0.46% -1.38% +2.33% -0.91% +0.46% Change
Company
Photocure ASA develops and markets pharmaceuticals and medical devices based on proprietary photodynamic technology. It operates through the Cancer and Dermatology segments. The Cancer segment consists of the sale from Hexvix to pharmaceutical wholesalers in Nordic markets and Cysview in the United... 
Sector
Pharmaceuticals
Calendar
08/26Earnings Release
Surperformance© rating of Photocure ASA
Trading Rating : - Investor Rating :
More about the company
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Financials ( NOK)
Sales 2014 140 M
EBIT 2014 8,00 M
Net income 2014 14,0 M
Debt 2014 168 M
Yield 2014 -
Sales 2015 121 M
EBIT 2015 48,0 M
Net income 2015 55,0 M
Debt 2015 193 M
Yield 2015 -
PER 2014 33,03
PER 2015 8,55
EV / Sales 2014 4,53x
EV / Sales 2015 5,45x
Capitalization 466 M
More Financials
Latest news on PHOTOCURE ASA
07/10 PHOTOCURE ASA : Expert Recommendations on the Clinical and Cost Effectiveness of..
07/01 PHOTOCURE ASA : Focus on acne
06/25 PHOTOCURE ASA : US Congressman Tom Reed Introduces Bill To Give Cancer Patients ..
06/23 PHOTOCURE ASA : GlobalData June 17th: Novel product launches to reinvigorate acn..
06/17 PHOTOCURE ASA : Focus on cervical cancer
05/07 PHOTOCURE ASA : Results for the first quarter 2014
04/28 PHOTOCURE ASA : Focus on cervical cancer
03/17 PHOTOCURE ASA : Focus on cervical cancer
02/28 PHOTOCURE ASA : Norway : Regulatory Update on Cevira
02/27 PHOTOCURE ASA : Results for the fourth quarter and full year 2013
2013 PHOTOCURE ASA : Regulatory Update on Cevira
2013 PHOTOCURE ASA : Norway : Photocure to present data on cevira at the Eurogin 2013..
More news
Comments 
Advertisement
Income Statement Evolution
Photocure ASA : Income Statement Evolution
More Financials
EPS Revisions
Photocure ASA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF